GlaxoSmithKline Pharmaceuticals Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
47664.08 Cr.
|
P/BV
|
28.50
|
Book Value (Rs.)
|
98.74
|
52 Week High/Low (Rs.)
|
3148/1921
|
FV/ML
|
10/1
|
P/E(X)
|
80.23
|
Bookclosure
|
07/11/2024
|
EPS (Rs.)
|
35.07
|
Div Yield (%)
|
1.14
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 959.80 | 841.49 | 2475.65 | 723.10 | 647.25 |
| | | | | |
Net CashFlow From Operating Activities | 582.02 | 484.23 | 810.75 | 577.93 | 490.50 |
Net Cash Used In Investing Activities | 8.71 | 807.85 | -405.51 | 418.59 | -56.84 |
Net Cash Used From Financing Activities | -561.50 | -1543.32 | -524.24 | -696.14 | -427.62 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 29.23 | -251.25 | -119.00 | 300.38 | 6.03 |
Cash And Cash Equivalents Begin of Year | 34.94 | 286.19 | 405.19 | 104.81 | 98.78 |
Cash And Cash Equivalents End Of Year | 64.17 | 34.94 | 286.19 | 405.19 | 104.81 |